Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
4.030
-0.460 (-10.24%)
At close: Jul 15, 2025, 4:00 PM
3.974
-0.057 (-1.40%)
After-hours: Jul 15, 2025, 6:50 PM EDT
Organogenesis Holdings Stock Forecast
Stock Price Forecast
The 2 analysts that cover Organogenesis Holdings stock have a consensus rating of "Buy" and an average price target of $6.5, which forecasts a 61.29% increase in the stock price over the next year. The lowest target is $6 and the highest is $7.
Price Target: $6.5 (+61.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Organogenesis Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +73.70% | Jul 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 → $6 | Hold | Maintains | $4 → $6 | +48.88% | Mar 5, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +24.07% | Jun 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $5 | Buy | Reiterates | $5 | +24.07% | Mar 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $5 | Buy | Initiates | $5 | +24.07% | Feb 7, 2024 |
Financial Forecast
Revenue This Year
487.36M
from 482.04M
Increased by 1.10%
Revenue Next Year
535.76M
from 487.36M
Increased by 9.93%
EPS This Year
-0.03
from -0.01
EPS Next Year
0.20
from -0.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 523.9M | 554.4M | 595.8M |
| Avg | 487.4M | 535.8M | 578.8M |
| Low | 441.5M | 512.1M | 556.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.7% | 13.8% | 11.2% |
| Avg | 1.1% | 9.9% | 8.0% |
| Low | -8.4% | 5.1% | 3.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.03 | 0.23 | 0.34 |
| Avg | -0.03 | 0.20 | 0.33 |
| Low | -0.03 | 0.17 | 0.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 68.9% |
| Avg | - | - | 64.1% |
| Low | - | - | 57.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.